209 related articles for article (PubMed ID: 19390931)
1. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.
Ohtani S; Terashima M; Satoh J; Soeta N; Saze Z; Kashimura S; Ohsuka F; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2009; 12(1):43-51. PubMed ID: 19390931
[TBL] [Abstract][Full Text] [Related]
2. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
4. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
6. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of claudin-4 in gastric carcinoma.
Zhu JL; Gao P; Wang ZN; Song YX; Li AL; Xu YY; Wang MX; Xu HM
World J Surg Oncol; 2013 Jul; 11():150. PubMed ID: 23822740
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
9. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
11. The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues.
Wang H; Yang X
Int J Clin Exp Pathol; 2015; 8(1):881-7. PubMed ID: 25755790
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas.
Paschoud S; Bongiovanni M; Pache JC; Citi S
Mod Pathol; 2007 Sep; 20(9):947-54. PubMed ID: 17585317
[TBL] [Abstract][Full Text] [Related]
14. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.
Resnick MB; Konkin T; Routhier J; Sabo E; Pricolo VE
Mod Pathol; 2005 Apr; 18(4):511-8. PubMed ID: 15475928
[TBL] [Abstract][Full Text] [Related]
15. Tight junction protein claudin 4 in gastric carcinoma and its relation to lymphangiogenic activity.
Shareef MM; Radi DM; Eid AM
Arab J Gastroenterol; 2015; 16(3-4):105-12. PubMed ID: 26526513
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas.
Aung PP; Mitani Y; Sanada Y; Nakayama H; Matsusaki K; Yasui W
Virchows Arch; 2006 Apr; 448(4):428-34. PubMed ID: 16328347
[TBL] [Abstract][Full Text] [Related]
17. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
18. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
19. Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.
Kwon CH; Park HJ; Lee JR; Kim HK; Jeon TY; Jo HJ; Kim DH; Kim GH; Park DY
Br J Cancer; 2014 Nov; 111(10):1993-2002. PubMed ID: 25211665
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
